SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors rally around the company's optical interconnect technology, with strong bullish sentiment following a CFO interview that dismissed short-seller concerns and highlighted ongoing engagement with hyperscalers. The community is actively discussing the stock's massive trading volume and the potential for a significant re-rating as the company moves toward scaling production and securing major purchase orders.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. remains the focal point of intense retail activity as investors digest recurring competition narratives alongside high-conviction sentiment regarding the company's potential in the peptide and GLP-1 telehealth space. The community is actively debating a potential short squeeze, with many users dismissing recent price volatility as buying opportunities while maintaining a bullish outlook on the stock's long-term growth and market position.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing extreme volatility driven by a massive, supply-constrained short squeeze that has left traders debating whether to ride the parabolic momentum toward record highs or brace for an inevitable, sharp correction. The community is deeply polarized, with many retail investors tracking aggressive call flow and institutional concentration, while others warn of a looming 'bagholder' scenario fueled by the company's significant debt and potential for share dilution.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing significant upward momentum driven by intense retail interest and investor optimism regarding its gallium nitride (GaN) power chip technology, which is viewed as a critical component for future AI data center infrastructure. While bulls are encouraged by potential long-term partnerships and the company's role in next-gen power architectures, the community is actively debating whether this price action is a fundamental re-rating or a speculative short squeeze, with many participants warning of the company's current lack of profitability.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is seeing intense investor activity driven by a strategic board overhaul, anticipation of major regulatory de-risking catalysts, and high-conviction institutional accumulation. The community is focused on the company's long-term potential as a critical power provider for AI data centers, while actively monitoring short-interest data and the upcoming criticality milestone for its Aurora reactor.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is seeing increased investor optimism driven by speculation that Dr. Houman Hemmati, a former company executive with experience in exosome and cell therapy development, is a leading candidate to head the FDA's CBER. Community discourse is highly bullish, with many investors anticipating that a new leadership appointment and the upcoming PDUFA date for deramiocel will serve as major catalysts for a potential breakthrough.

Chip

CHIP is gaining significant community attention and trending volume following its debut on major trading platforms like Robinhood. Traders are actively debating the token's long-term utility versus its meme coin status while navigating volatile execution experiences on retail exchanges.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is drawing significant attention as investors await clinical updates and a potential partnership or buyout, following recent institutional stake increases and the presentation of preclinical data for SLS009. The community is deeply divided, with bulls pointing to institutional accumulation and the potential curative nature of their pipeline, while bears voice skepticism regarding the company's financial history and the timeline for trial data releases.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is surging following the release of positive registrational Phase 2 data for miv-cel, with the community highlighting its potential to become the first approved CAR T-cell therapy for autoimmune diseases like stiff-person syndrome. Investors are actively discussing the strong clinical endpoints and future commercialization prospects, while closely watching for potential acquisition interest given the company's strong institutional backing and best-in-class trial results.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors rally behind its deepening collaboration with Nvidia on edge AI systems and positive momentum from recent QNX operating system design wins. The community is actively discussing a potential long-term transformation into a critical software platform for industrial and autonomous infrastructure, leading to intense speculation about institutional accumulation and a potential price breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tributary Capital Management LLC Boosts Stock Position in CONMED Corporation $CNMD

Tributary Capital Management LLC boosted its holdings in CONMED Corporation (NYSE:CNMD - Free Report) by 29.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 268,896 shares of the company's stock after purch...

CONMED Corporation (NYSE:CNMD) Receives Consensus Recommendation of "Reduce" from Analysts

CONMED Corporation (NYSE:CNMD - Get Free Report) has been given an average recommendation of "Reduce" by the eight analysts that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and seven have given a hold recommendation to the co...

CONMED (NYSE:CNMD) Upgraded to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded CONMED from a "buy" rating to a "strong-buy" rating in a research note on Tuesday...

SG Americas Securities LLC Sells 51,018 Shares of CONMED Corporation $CNMD

SG Americas Securities LLC cut its stake in CONMED Corporation (NYSE:CNMD - Free Report) by 79.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

CNMD's high-margin platforms, supply-chain recovery and margin expansion plans support growth, though tariffs and portfolio shifts weigh on near-term results.

CONMED (NYSE:CNMD) Rating Lowered to Buy at Wall Street Zen

Wall Street Zen cut CONMED from a "strong-buy" rating to a "buy" rating in a research note on Monday...

Allspring Global Investments Holdings LLC Grows Stake in CONMED Corporation $CNMD

Allspring Global Investments Holdings LLC boosted its stake in shares of CONMED Corporation (NYSE:CNMD - Free Report) by 47.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 416,432 shares of the company's stock afte...

CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Companys management will host...

CONMED Corporation $CNMD Shares Sold by Pacific Capital Partners Ltd

Pacific Capital Partners Ltd cut its holdings in shares of CONMED Corporation (NYSE:CNMD - Free Report) by 77.1% during the fourth quarter, according to its most recent Form 13F filing with the...

Wedge Capital Management L L P NC Buys 71,282 Shares of CONMED Corporation $CNMD

Wedge Capital Management L L P NC lifted its position in shares of CONMED Corporation (NYSE:CNMD - Free Report) by 165.2% during the 4th quarter, according to its most recent filing with the...

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Current Price	$38.35
Prev Close	$39.68
Open	$39.72
Dividend Yield	N/A
50-Day Moving Average	$39.52
Beta	0.93
Avg. Volume	428,899.43
PE Ratio	25.31

52-Week High	$61.08
52-Week Low	$33.21
Market Capitalization	$1.22B
EPS (Annual)	$1.51
Price to Book	1.15
Revenue Per Employee	$352,434.61

CNMD
Conmed Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CNMD News

CNMDConmed Corp.